日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of the COVID-19 Pandemic on People Living with Rheumatoid Arthritis: Experiences and Preferences in Accessing Healthcare Across Five Countries

新冠疫情对类风湿性关节炎患者的影响:五个国家患者就医经历及偏好

Saraux, Alain; da Mota, Licia Maria Henrique; Dixit, Sanjay; Gibofsky, Allan; Matsubara, Tsukasa; Mulvey, Amy; Koehn, Cheryl; Mortezavi, Mahta; Segovia, Michelle; Kessouri, Meriem

Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary

处方医生对生物类似药应用及临床药理学潜在作用的看法:研讨会总结

Shubow, Sophie; Sun, Qin; Nguyen Phan, Ai Len; Hammell, Dana C; Kane, Maureen; Lyman, Gary H; Gibofsky, Allan; Lichtenstein, Gary R; Bloomgarden, Zachary; Cross, Raymond K; Yim, Sarah; Polli, James E; Wang, Yow-Ming

An online survey among US patients with immune-mediated conditions: Attitudes about biosimilars

一项针对美国免疫介导疾病患者的在线调查:对生物类似药的态度

Gibofsky, Allan; Jacobson, Gary; Franklin, Archie; O'Hara-Levi, Shannan; Peyrin-Biroulet, Laurent; McGrath, Melissa; McCabe, Dorothy

US rheumatologists' beliefs and knowledge about biosimilars: a survey

美国风湿病学家对生物类似药的看法和知识:一项调查

Gibofsky, Allan; McCabe, Dorothy

Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial

Lorecivivint,一种新型关节内注射的 CDC 样激酶 2 和双特异性酪氨酸磷酸化调节激酶 1A 抑制剂及 Wnt 通路调节剂,用于治疗膝骨关节炎:一项 II 期随机试验

Yazici, Yusuf; McAlindon, Timothy E; Gibofsky, Allan; Lane, Nancy E; Clauw, Daniel; Jones, Morgan; Bergfeld, John; Swearingen, Christopher J; DiFrancesco, Anita; Simsek, Ismail; Tambiah, Jeyanesh; Hochberg, Marc C

Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey

COVID-19 对风湿病弱势患者的影响:一项全球调查的结果

Mehta, Bella; Jannat-Khah, Deanna; Fontana, Mark Alan; Moezinia, Carine J; Mancuso, Carol A; Bass, Anne R; Antao, Vinicius C; Gibofsky, Allan; Goodman, Susan M; Ibrahim, Said

Geographical variations in COVID-19 perceptions and patient management: a national survey of rheumatologists

风湿病学家对新冠肺炎的认知和患者管理存在地域差异:一项全国性调查

Mehta, Bella; Jannat-Khah, Deanna; Mancuso, Carol A; Bass, Anne R; Moezinia, Carine J; Gibofsky, Allan; Goodman, Susan M; Ibrahim, Said

Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists

羟氯喹和氯喹在新冠肺炎中的应用:风湿病学家处方模式调查

Mehta, Bella; Moezinia, Carine J; Jannat-Khah, Deanna; Gibofsky, Allan; Tornberg, Haley; Pearce-Fisher, Diyu; Goodman, Susan M; Salmon, Jane E; Ibrahim, Said

Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis

一项针对美国类风湿性关节炎患者的行为干预整群随机试验,旨在将达标治疗方法纳入患者的护理中

Harrold, Leslie R; Reed, George W; John, Ani; Barr, Christine J; Soe, Kevin; Magner, Robert; Saunders, Katherine C; Ruderman, Eric M; Haselkorn, Tmirah; Greenberg, Jeffrey D; Gibofsky, Allan; Harrington, J Timothy; Kremer, Joel M

Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review

类风湿性关节炎生物制剂减量治疗:系统性文献综述

Lau, Chak Sing; Gibofsky, Allan; Damjanov, Nemanja; Lula, Sadiq; Marshall, Lisa; Jones, Heather; Emery, Paul